for Health Care Providers
Antiviral Treatment Eligibility
Contraindications
- Interferon (if contraindicated, patient should not receive any therapy since ribavirin alone is not useful)
- Platelet count ≤70,000 cells/µL
- ANC ≤1,500 cells/µL
- Life-determining extrahepatic disease (malignancy, unstable angina, severe COPD)
- Clinically decompensated liver disease
- Uncontrolled autoimmune disorders
- Pregnancy or planned pregnancy in patient or partner, or unwillingness to use birth control
- Documented nonadherence to prior therapy, or failure to complete pretreatment evaluation appointments or procedures
- Inability to self-administer or to arrange administration of parenteral medication
- Severe uncontrolled psychiatric disease, particularly depression with current suicidal risk
- Ongoing injection drug use
- Ongoing alcohol abuse
- Ribavirin (if contraindicated, interferon monotherapy can be considered)
- Serum creatinine ≥1.5 g/dL or creatinine clearance ≤50 ml/min
- Hemoglobin <12 g/dL in men or <11 g/dL in women
- Thalassemia or other hemoglobinopathy
- Significant cardiac disease (arrhythmias, angina, CABG, MI) in past 12 months
- Pregnancy or planned pregnancy in patient or partner, or unwillingness to use birth control
Next: Pretreatment Assessment

